AIIMS Jammu & 4baseCare sign MoU to launch Centre for Advanced Genomics & Precision Medicine

New Delhi: AIIMS Jammu and 4baseCare have signed an MoU to launch the Centre for Advanced Genomics and Precision Medicine. This state-of-the-art facility will offer cutting-edge genomic technologies to transform patient care across diverse medical fields, including cancer, rare diseases, reproductive health, and public health.

Commenting on the collaboration, 𝐏𝐫𝐨𝐟. (𝐃𝐫.) 𝐒𝐡𝐚𝐤𝐭𝐢 𝐊𝐮𝐦𝐚𝐫 𝐆𝐮𝐩𝐭𝐚, Executive Director and CEO of AIIMS Jammu, emphasized the profound impact of this initiative, stating:-“For every patient we treat, we are treating a mother, a father, a sister, or a brother. This partnership is our promise to every family who walks through our doors that we will do everything in our power to bring them the care they deserve.”

Echoing this sentiment, 𝐇𝐢𝐭𝐞𝐬𝐡 𝐆𝐨𝐬𝐰𝐚𝐦𝐢, CEO of 4baseCare, highlighted the shared mission, “By working together, AIIMS Jammu and 4baseCare are committed to making sure that no patient is left behind. We are fighting for a future where every person has access to the best care, the best treatments, and most importantly, the best chance at survival.”

The Centre for Advanced Genomics and Precision Medicine will focus on the following areas Precision Oncology The centre aims to redefine cancer care by focusing on targeted, biomarker-driven therapies. This approach ensures personalized treatment plans that improve outcomes and enhance quality of life for cancer patients. Rare Diseases Rare diseases often pose diagnostic challenges, leaving patients and families searching for answers.

Through advanced genomics, the centre is committed to unlocking these mysteries and providing actionable insights for some of the world’s rarest conditions. Reproductive Medicine (NIPT/PGS/PGD) By integrating early genetic insights into prenatal and fertility care, the centre is revolutionizing reproductive medicine.

Technologies such as Non-Invasive Prenatal Testing (NIPT), Preimplantation Genetic Screening (PGS), and Preimplantation Genetic Diagnosis (PGD) are empowering families with knowledge and options for a healthier future. Public Health – COVID and Beyond: The pandemic highlighted the critical need for precision-driven technologies in public health. This centre will continue to empower public health initiatives by providing genomic solutions for current and future health challenges.